About turoctoco g alfa human
Recombinant factor VIII clotting factor
Used for
- Treats and prevents bleeding in haemophilia A.
- Used to control bleeding during surgery in haemophilia A.
Usual adult dose
Individualised by weight, bleeding severity, and treatment goal; commonly 20–50 IU/kg per dose.
Usual dose in children
Individualised by weight, bleeding severity, and treatment goal; commonly 20–50 IU/kg per dose.
Common side effects
- Injection-site reactions
- Headache
- Fever
- Development of factor VIII inhibitors
Important warnings
- Factor VIII inhibitors can reduce treatment effectiveness.
- Severe allergic reactions may occur.
- Not for treatment of von Willebrand disease.
- Dose and monitoring require specialist oversight.
Pregnancy
Limited human data; use only when clearly needed and under specialist supervision.
Breastfeeding
Limited data; discuss use with a healthcare professional.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.